ZEINAB BERJAOUI: Open Payments
NPI 1659972339 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 45 payments from 17 companies in 2025. Trend: 2023 $1,366 · 2024 $1,611 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $241 |
| ARGENX US, INC. | 6 | $172 |
| Fresenius Kabi USA, LLC | 5 | $159 |
| Amgen Inc. | 9 | $150 |
| TG Therapeutics, Inc. | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $147 |
| Regeneron Healthcare Solutions, Inc. | 2 | $122 |
| Lilly USA, LLC | 2 | $119 |
| Pharmacosmos Therapeutics Inc. | 1 | $107 |
| Alexion Pharmaceuticals, Inc. | 2 | $106 |
Products named: TREMFYA, BRIUMVI, LIBTAYO, ENTYVIO, VYVGART HYTRULO, EVENITY, MONOFERRIC, KISUNLA.
Industry payments across MI — which companies pay providers there.
